Literature DB >> 6496184

High risk of cerebro-cardiovascular morbidity in well treated male hypertensives. A retrospective study of 40-59-year-old hypertensives in a Swedish primary care district.

L Lindholm, G Ejlertsson, B Scherstén.   

Abstract

In a retrospective study of 121 hypertensives aged 40-59 years in comparison with 138 controls selected from the population in the same primary care district, male hypertensives had a high odds ratio of cerebro-cardiovascular (CCV) diseases even when their blood pressure had been well treated. The estimated odds ratio (corrected for small numbers) was 13.7 (2.5-76.7). In female hypertensives there was a trend towards more CCV diseases than in their controls. Although the hypertensives' blood pressure was reduced in accordance with what has been internationally accepted, their values were still at least 10-11 mmHg higher than those of the controls. A reduction of this magnitude may be accomplished by (further) weight reduction and, probably, intervention with factors linked to obesity. This may be one way to reduce the excess risk in hypertensives.

Entities:  

Mesh:

Year:  1984        PMID: 6496184     DOI: 10.1111/j.0954-6820.1984.tb03802.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  8 in total

1.  Treating hypertension: how low is optimal and does aspirin help?

Authors:  R W Alexander
Journal:  Curr Hypertens Rep       Date:  1999 Feb-Mar       Impact factor: 5.369

Review 2.  The management of hypertension in Canada: a review of current guidelines, their shortcomings and implications for the future.

Authors:  F A McAlister; N R Campbell; K Zarnke; M Levine; I D Graham
Journal:  CMAJ       Date:  2001-02-20       Impact factor: 8.262

3.  Attenuation of contractile responses to sympathetic co-transmitters in veins from subjects with essential hypertension.

Authors:  H Lind; D Erilnge; J Brunkwall; L Edvinsson
Journal:  Clin Auton Res       Date:  1997-04       Impact factor: 4.435

Review 4.  First-line treatment in hypertension. Role of perindopril.

Authors:  A Zanchetti
Journal:  Drugs       Date:  1990       Impact factor: 9.546

5.  The impact of cardiovascular risk-factor profiles on blood pressure control rates in adults from Canada and the United States.

Authors:  Finlay A McAlister; Cynthia Robitaille; Cathleen Gillespie; Keming Yuan; Deepa P Rao; Steven Grover; Sulan Dai; Helen Johansen; Michel Joffres; Fleetwood Loustalot; Norm Campbell
Journal:  Can J Cardiol       Date:  2013-03-01       Impact factor: 5.223

Review 6.  The J-curve. The importance of gradual reduction of blood pressure.

Authors:  M Luque-Otero; C Fernandez-Pinilla
Journal:  Drugs       Date:  1992       Impact factor: 9.546

7.  CD39/NTPDase-1 activity and expression in normal leukocytes.

Authors:  E Dianne Pulte; M Johan Broekman; Kim E Olson; Joan H F Drosopoulos; Jorge R Kizer; Naziba Islam; Aaron J Marcus
Journal:  Thromb Res       Date:  2007-06-07       Impact factor: 3.944

8.  2017 ACC/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular Risk.

Authors:  Lisandro D Colantonio; John N Booth; Adam P Bress; Paul K Whelton; Daichi Shimbo; Emily B Levitan; George Howard; Monika M Safford; Paul Muntner
Journal:  J Am Coll Cardiol       Date:  2018-09-11       Impact factor: 24.094

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.